Trade names from ondansetron-teva to oralcon - Electronic medicinal guide TALKDRUGS

Solution for intravenous and intramuscular injection 2 mg / ml.

Solution for intravenous and intramuscular administration 4 mg / 2 ml or 8 mg / 4 ml.

Solution for intravenous and intramuscular injection of 4 mg / 2 ml or 8 mg / 4 ml (2 mg / ml).


Tablets, film-coated, 4 mg, 8 mg

Sandoz GmbH Austria

Drops for ingestion 10 mg / ml.

Solution for intravenous administration 0.25 mg / 5 ml.

Solution for intravenous and intramuscular injection.
medac GmbH Germany

Concentrate for the preparation of a solution for infusions, 40 mg / ml.

Tolmar, Corp. Panama
Concentrate for the preparation of a solution for intravenous and intravenous administration, 2 mg / ml.
Solution for intradermal administration 62.5 μg / ml.

Tablets coated with enteric-coated 10 mg or 20 mg.


TEVA, LLC Russia

Eye drops, 0,1%.

Concentrate for solution for infusion, 10 mg / ml.

Powder for solution for injection in bottles of 1.0 g.
Tablets, film-coated, 20 mg and 40 mg.
Tablets, 0.088 mg, 0.18 mg, 0.7 mg.

Tablets, film-coated, 10 mg.

Eye drops.

Eye drops, 2.0%.

Vaginal suppositories 300 mg / 10 mg.
Solution for intravenous administration is 550 μmol / ml.

Solution for intravenous and intra-arterial administration, 240 mg iodine / ml, 300 mg iodine / ml, 320 mg iodine / ml, 350 mg iodine / ml.

Solution for injection 40 mg / ml + 5 μg / ml and 40 mg / ml + 10 μg / ml.

Tablets are sublingual, 100 IR and 300 IR.

The coated tablets are 150 μg + 30 μg.